Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 07:37
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
INFLAME has accelerated its Gross Margin to 35.03% (quarterly cadence), up from 10.3%.
The company also accelerated its Marginal Operating Leverage to (quarterly cadence), up from 3.89%. Additionally, INFLAME's Revenue Growth Yoy accelerated to (quarterly cadence), up from -0.9%. However, the company's Close Price decelerated to (daily cadence), down from 224 INR. The daily volume also increased to 15,000 shares, up from 8,919 shares.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 35.03 % | 10.3 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 10.3 % | 3.89 | ▲ |
| REVENUE_GROWTH_YOY | 39.5 % | -0.9 | ▲ |
| PRICE_CHANGE_PERCENT | -1.719 % | — | - |
| DAILY_VOLUME | 15,000 shares | 8,919 | ▲ |
| CLOSE_PRICE | 220.15 INR | 224 | ▼ |
Cite this
Source: Samhati evidence synthesis for INFLAME (2026-10-21). Observation: INFLAME has accelerated its Gross Margin to 35.03% (quarterly cadence), up from 10.3%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/inflame
Filing step-changes